Skip to main content
Toggle navigation
Login
Search
Home
Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Norman J. Siegel New Member Outstanding Science Award
John Howland Award
Mary Ellen Avery Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
PROSPER Diversity Award
ASPN Founders’ Award
David G. Nichols Health Equity Award
ASPN Mid-Career Award
Awarded Part 4 Maintenance of Certification (MOC) Credit
Poster Icons
Awarded Part 4 Maintenance of Certification (MOC) Credit
Hematology/Oncology 1: Pediatric Oncology
Home
Hematology/Oncology 1: Pediatric Oncology
Hematology/Oncology 1: Pediatric Oncology
Type here to filter the list
Hematology/Oncology 1: Pediatric Oncology
Favorite
100 - Influence of Preferred Language on Time to Diagnosis of Pediatric Leukemia
Favorite
101 - Navigating Conflicting Communication Preferences in Serious Illness: Recommendations from Pediatric Patients with Advanced Cancer, Parents, and Oncologists
Favorite
102 - Outcomes after Implementation of an Emergency Department Fever and Neutropenia Protocol in Pediatric Oncology Patients
Favorite
103 - Preferred Language, Acuity at Presentation, and Intensive Care Unit (ICU) Level Care in Children with Acute Myeloid Leukemia
Favorite
104 - Preparation for implementation: technical and procedural challenges and adaptations for delivering an online fertility preservation decision tool to adolescents
Favorite
105 - Sodium Glucose Cotransporter 2 inhibitor (SGLT2i) Use in a Pediatric Patient Receiving Cisplatin
Favorite
106 - Utilization of Integrative Medicine Services among Survivors of Childhood, Adolescent and Young Adult (AYA) Cancer
Favorite
091 - Bacterial (Non-Clostridium Difficile) and Parasitic Stool Studies Have Limited Utility in Pediatric Hematopoietic Stem Cell Transplant Patients
Favorite
092 - Characterization and Assessment of Central Line Associated Bloodstream Infections Requiring Hospitalization in Pediatric Oncology Patients
Favorite
093 - Development of a physical activity and education module-containing mobile application for pediatric cancer patients and providers
Favorite
094 - Dual Inhibition of PAX3-FOXO1 in Rhabdomyosarcoma
Favorite
095 - Exploratory Analysis of Kidney Injury Biomarkers in Pediatric Cancer Survivors that received Cisplatin Chemotherapy: Pilot Study
Favorite
096 - Exploring Family Perspectives on Integrative and Complementary Medicine Practices in Pediatric Hematology/Oncology
Favorite
097 - Genetic differences between primary and metastatic Ewing Sarcoma: implications for targeted therapeutics
Favorite
098 - Immunity to Pneumococcus in Childhood Cancer Survivors
Favorite
099 - Infectious Disease Risk Factors and Incidence of Bacteremia and Febrile Neutropenia During COVID-19
Favorite